New Joint Venture Company Acquires Epax from Austevoll Seafood

Trygg Pharma AS—a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today)—has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries "Epax"), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world's premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.

Please see the following URls for further information.

http://www.huginonline.no/AKBM/logo.jpg

http://www.akerbiomarine.com